Authors:
Brewer, M
Utzinger, U
Satterfield, W
Hill, L
Gershenson, D
Bast, R
Wharton, JT
Richards-Kortum, R
Follen, M
Citation: M. Brewer et al., Biomarker modulation in a nonhuman rhesus primate model for ovarian cancerchemoprevention, CANC EPID B, 10(8), 2001, pp. 889-893
Authors:
Ibrahim, NK
Valero, V
Rahman, Z
Theriault, RL
Walters, RS
Buzdar, AU
Booser, DJ
Holmes, FA
Murray, DJ
Willey, J
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation, CANCER INV, 19(5), 2001, pp. 459-466
Authors:
Wacke, R
Rohde, B
Engel, G
Kundt, G
Hehl, EM
Bast, R
Seiter, H
Drewelow, B
Citation: R. Wacke et al., Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics, EUR J CL PH, 56(1), 2000, pp. 43-48
Authors:
Ibrahim, NK
Rahman, Z
Valero, V
Willey, J
Theriault, RL
Buzdar, AU
Murray, JL
Bast, R
Hortobagyi, GN
Citation: Nk. Ibrahim et al., Phase II study of vinorelbine administered by 96-hour infusion in patientswith advanced breast carcinoma, CANCER, 86(7), 1999, pp. 1251-1257